Zantac Recall: What is NDMA and Why is it Dangerous?

By Lee Rosenfeld

Apr 27

zantac cancer lawsuits, zantac cancer lawyers, zantac recall,

If you’ve watched the news at all recently, you’ve likely heard about the Zantac Recall. Zantac, a very common and now recalled antacid medication, is now considered dangerous to humans because it is linked to a dangerous chemical impurity known as NDMA (N-Nitroso-dimethylamine).

Zantac Recall: What is NDMA?

NDMA is a yellow liquid which has no distinct odor. It is produced in the U.S. only for use as a research chemical. NDMA was used to make rocket fuel, but this use was stopped after unusually high levels of this compound were found in air, water, and soil samples collected near a rocket fuel manufacturing plant. NDMA is, however, unintentionally formed during various manufacturing processes at many industrial sites and in air, water, and soil from reactions involving other chemicals called alkylamines. Alkylamines are both natural and man-made compounds which are found widely distributed throughout the environment. NDMA has been classified by the Environmental Protection Agency (EPA) as a probable human carcinogen, meaning it is a substance that is probable to cause cancer in humans. Furthermore, NDMA has been found in dangerously high levels in Zantac and linked to at least 20 different cancers. The FDA also has found that NDMA levels in Zantac products can increase with time and temperature posing a risk to consumers, and therefore the agency has issued a Zantac recall and requested the withdrawal of all Zantac products from the U.S. market.

Zantac Dangers: How Do You Know if You Have Been Affected and Should You Stop Taking Zantac?

The health effects of overexposure to NDMA include jaundice, nausea, fever, vomiting, abdominal cramps, and dizziness. High levels of exposure can also cause reduced function of the kidneys and lungs. If you are experiencing one or more of these symptoms currently, they could be attributed to your Zantac use. The FDA recommends that consumers stop taking any over-the-counter Zantac they may currently have. Patients taking prescription medication should speak with their health care professional about other treatment options before stopping the medicine. Multiple drugs are approved for the same or similar uses as Zantac.

Do Other Antacid Products Contain NDMA?

To date, FDA’s testing has not found NDMA in products used for similar treatment like famotidine (Pepcid), cimetidine (Tagamet), esomeprazole (Nexium), lansoprazole (Prevacid) or omeprazole (Prilosec). Talk to your doctor about what you can take in place of your Zantac or ranitidine prescription.

Does Zantac Really Cause Cancer?

Prolonged exposure to dangerous levels of NDMA can cause cancer. Zantac has been found to contain and even break down into dangerous levels of NDMA. Therefore, prolonged exposure to Zantac can cause prolonged exposure to NDMA, which can cause cancer. If you have taken Zantac for at least one year and have been diagnosed with cancer, Messa & Associates can help you file your claim for compensation. During this time of quarantine and social-distance, we have created a fully digital sign-up process. You can consult with an attorney over the phone and have all of your questions answered before you sign any documents. When you’re ready, you can read and sign all documents from your computer, tablet, or phone. Everything can be done from the comfort of your own home.

Call 877-637-7252 or submit an online inquiry if you would like to speak with someone about a potential Zantac cancer claim. If you want to file your claim for compensation now, simply click the ‘Sign-Up’ link below.

About the Author

For more than twenty years, Mr. Rosenfeld has successfully represented victims of personal injuries. From 1995 to 2005, he worked for a Philadelphia-based trial firm and developed his substantial litigation experience. In 2006, Mr. Rosenfeld launched his own firm aimed at maximizing his clients’ recoveries in serious injury claims and providing them with compassion and respect. Messa & Associates, P.C. was happy to welcome Mr. Rosenfeld to the firm in 2007.